Showing 25–36 of 81 results
Ksenya Cohen Katsenelson, Ph.D. Group Leader, R&D, Eurofins Discovery, San Diego, CA Chao-Tsung Yang, Ph.D. Group Leader, R&D, Eurofins DiscoverX,…
Read MoreThrough early discovery, screening, characterization, and particularly for market release and commercialization of biologics, drug candidates require physiologically relevant, functional…
Read MoreAn Application Note on automating Eurofins DiscoverX Cell-Based PathHunter® PD-1 Signaling Bioassay to bring high-throughput efficiencies to assay workflows. The…
Read MoreIn this study, we describe the evaluation of a cell-based protein stability assay using β-galactosidase fragment complementation technology performed in…
Read MoreAs newer, cutting-edge therapeutic technologies emerge, an increasing need for rapid and reliable screening tools follows.
Read MoreDiscoveRx offers an industry-leading portfolio of over 600 naturally coupled human and ortholog G-protein coupled receptor (GPCR) cell lines designed…
Read MoreLearn how KILR® cytotoxicity assays provide a simple, non-radioactive and dye free method to specifically measure target cell death in…
Watch NowLearn how InCELL cell-based binding assays can be used to detect compound cell entry and engagement to specific targets including…
Watch NowLearn about several GPCR assays and which ones to use and why for your research and drug discovery and development…
Watch Now
